Ketamine for Anxiety

Overview: Ketamine, a synthetic anesthetic with psychedelic-like effects, has a rich history in medicine and recent recognition for its therapeutic potential in treating anxiety and depression. Esketamine, a derivative, is FDA-approved for treatment-resistant depression. Despite its established safety as an anesthetic, ketamine's use beyond clinical settings requires careful consideration of risks. Research suggests ketamine's swift relief for anxiety, even in treatment-resistant cases. Mechanisms like NMDA receptor interaction and BDNF increase contribute to its effects. Set and setting play crucial roles in its safe use. While benefits last 1-2 weeks, uncertainties and small-scale trials underscore the need for caution and professional guidance. Ketamine shows promise for anxiety treatment, but ongoing research is vital to understand its optimal use and long-term effects. Staying informed and consulting healthcare professionals can help to ensure a balanced approach to incorporating ketamine into mental health treatment.

‍

What is Ketamine? 

Ketamine is a dissociative anesthetic drug with psychedelic-like effects that has been used in medicine for more than 50 years. Not a plant medicine or classic psychedelic drug, ketamine is a synthetic compound discovered by Calvin Lee Stevens in 1962.

‍

Ketamine was first approved by the U.S. Food and Drug Administration (FDA) in 1970 for the induction and maintenance of anesthesia in surgery under the brand name “Ketalar.” Ketamine was used widely during the Vietnam War due to its favorable safety profile and effectiveness as a field anesthetic. 

‍

Despite primarily being used in medicine, ketamine's effects on consciousness, namely its ability to produce feelings of euphoria and disassociation, made it a popular recreational drug. However, ketamine was classified as a Schedule 3 substance in 1999 after an increase in recreational use, which defined it as a drug with a moderate to low potential for physical and psychological dependence and restricted its availability. 

‍

Recently, research has demonstrated the promising therapeutic potential of ketamine. Dr. John Krystal at Yale University accidentally discovered ketamine's powerful antidepressant effects when applying low doses to surgical patients which kickstarted research into its effects on mental health.

‍

Esketamine, a drug closely related to ketamine, has recently been approved by the FDA for the treatment of treatment-resistant depression (TRD) under the brand name “Spravato.” Spravato is administered as a nasal spray and is typically used in conjunction with an antidepressant.

‍

Ketamine is also used “off-label” to treat various mental health conditions, including depression, anxiety, and post-traumatic stress disorder (PTSD). Off-label means that clinicians may use ketamine for these conditions, often in the form of intravenous infusions, or intramuscular injections, because it is approved for anesthesia. 

‍

‍

Ketamine as an Emerging Treatment for Anxiety

Ketamine's effects on mental health are most known for offering rapid relief from treatment-resistant conditions like anxiety and depression. Other mental health and pain conditions like substance use disorders, PTSD, chronic pain, or OCD have also been shown to be affected positively by ketamine treatment.

‍

Recently research into ketamine for anxiety has become an important topic as rates of anxiety continue to grow. A survey in 2005 showed that 12% of Americans have  a "persistent fear of one or more social situations."

‍

For some people, successfully treating their anxiety can be difficult. Specific cases can even be treatment-resistant, meaning conventional pharmaceutical medications or psychological supports have no positive impact. Promisingly, research has shown that ketamine can offer lasting relief in some treatment-resistant cases.

‍

Ketamine may prove effective in cases of moderate anxiety, but its clearest benefits seem to be for more challenging anxiety conditions and depression. Early findings suggest promise in alleviating anxiety, targeting symptoms such as irritability and agitation.

‍

Notable instances of ketamine's potential for anxiety treatment include:

• Suicidal Thoughts: Rapid reduction of suicidal thoughts has been observed in conjunction with decreases in anxiety and depression.

• Social and General Anxiety: Ketamine appears to swiftly relieve symptoms of both social and general anxiety, leading to improved social functioning.

• Anxiety and Depression in Hospice: For individuals in hospice care, who may not have the luxury of time for traditional antidepressants to take effect, oral ketamine has shown rapid relief in certain cases.

‍

Despite these potential benefits, it's crucial to acknowledge that outcomes are uncertain, and positive effects may be temporary. Numerous clinical trials investigating ketamine for anxiety have been relatively small in scale, and as such, their findings should be approached with caution.

‍

Therapeutic Mechanisms of Ketamine for Anxiety

The exploration of ketamine's specific impact on anxiety is an ongoing endeavor, with early data and conceptual frameworks emerging. Here are some examples of ketamine's brain activity which may be responsible for its positive effects on anxiety:

• NMDA Receptors: Receptors are specialized proteins located on the surface or within brain cells (neurons) that are crucial for transmitting signals within the body. Ketamine hampers activity at N-methyl-D-aspartate (NMDA) receptors, triggering an increase in glutamate production. This activity is what produces the experiential, dissociative effects of ketamine, and is believed to facilitate the formation of new connections in the brain.

• Opioid Receptors: Stanford research indicates that ketamine interacts with opioid receptors and that this interaction may be necessary for its antidepressant effects. 

• BDNF (Brain-Derived Neurotrophic Factor): Ketamine is known to increase the levels of BDNF, a protein that plays a role in promoting the survival, growth, and maintenance of neurons. The increase in BDNF levels is thought to contribute to the changes in brain structure and function observed in response to ketamine. These “neuroplastic” changes are believed to be part of the mechanism underlying the therapeutic effects of ketamine.

• mTOR (Mammalian Target of Rapamycin): Ketamine also interacts with the mTOR pathway. The activation of mTOR has been associated with the rapid and sustained therapeutic effects of ketamine. 

‍

In addition to these mechanisms, the subjective experience of ketamine itself is speculated to play a pivotal role. Consuming a sub-anesthetic dose, where consciousness is maintained, but a psychedelic-like experience occurs, can offer unique and sometimes insightful perspectives on one's life and situation.

‍

Furthermore, ketamine has demonstrated the ability to induce mystical-type experiences, which have proven significant in the treatment of alcohol misuse. with ketamine. Similar to other psychedelics, the therapeutic potential of ketamine for anxiety may be linked to these mystical-type experiences.

‍

Ketamine for Anxiety: Risks and Safety Considerations

Here are some factors to bear in mind when contemplating the use of ketamine for anxiety:

• Method of Ingestion: Intravenous and intramuscular administration of ketamine seem to produce the most rapid and pronounced effects on anxiety. However, promising results are also emerging from oral and nasal routes.

• Dose: While limited research supports small doses of ketamine, for addressing social anxiety, higher doses administered intravenously may be more effective.

• Frequency of Treatment: Research indicates that the benefits of ketamine tend to last approximately 1-2 weeks. Various treatment protocols span a few months, with administration frequencies varying. It's crucial to consider the duration and frequency based on individual needs and responses.

‍

Set and Setting for Ketamine

“Set and setting” refers to the psychological and environmental factors that can influence the subjective experience of an individual using a psychoactive substance like ketamine.

‍

Ketamine is considered safe and effective when used in controlled clinical contexts under medical supervision. Its use outside of clinical settings can also be done safely and effectively but requires careful consideration of set, setting, and dosage:

• Controlled Clinical Contexts: When administered in controlled clinical settings, ketamine is closely monitored by healthcare professionals, ensuring a safe and effective experience for the patient. The controlled environment, medical supervision, and precise dosing contribute to its safety and therapeutic efficacy.

• Outside Clinical Contexts: When ketamine is used outside of clinical settings, factors such as the individual's mental state (set), the physical environment (setting), and the dosage become critical. The psychological and emotional state of the person, along with the surroundings, can significantly impact the ketamine experience.

• Consideration of Set, Setting, and Dosage: To enhance safety and positive outcomes, careful attention should be given to the individual's mindset, the environment in which ketamine is used, and the appropriate dosage. These considerations help mitigate potential risks and promote a more controlled and beneficial experience.

‍

Risks Associated with Ketamine

As mentioned earlier, ketamine holds approval as an anesthetic agent with a well-established safety profile. Nevertheless, it's important to acknowledge the inherent risks associated with both therapeutic and recreational ketamine use.

‍

Potential risks to consider include:

• Unpleasant Effects: While many individuals experience positive effects, some may experience short-lived side effects that could be unpleasant or overwhelming. These may encompass feelings of strangeness, dissociation, blurred vision, dry mouth, poor balance, and dizziness.

• Abuse Potential: Ketamine has a recognized moderate potential for abuse, especially when utilized outside clinical settings. While moderate use is generally deemed safe, chronic use — though not extensively studied — may be linked to adverse effects on kidney and bladder health.

• Impact on Mental Health: Ketamine can be an effective treatment for various mental health conditions, but caution is advised, especially in cases of severe psychiatric or psychotic disorders. Individuals with a personal or family history of schizophrenia or psychosis are generally recommended to avoid ketamine or other psychedelics. Those with underlying mental health conditions are advised to consult qualified healthcare professionals for personalized guidance.

‍

In navigating the potential risks associated with ketamine use, an informed and cautious approach, coupled with professional guidance, ensures a more comprehensive understanding of its implications.

‍

Ketamine for Anxiety: Conclusion

Ketamine, traditionally used as an anesthetic, has garnered attention for its use in treating mental health conditions, particularly anxiety and depression.

‍

Recent research suggests its potential effectiveness, often yielding therapeutic effects lasting 1-2 weeks. Despite its historical use, exploring ketamine's nuanced impact on mental health is a relatively new frontier.

‍

While promising, the optimal use of ketamine for mental health needs further research. Questions remain about the most effective administration methods, associated benefits, and potential risks. 

‍

In the journey toward understanding ketamine's role in mental health, it's important to acknowledge ongoing investigations into long-term effects and the development of optimal treatment protocols.

‍

Given the dynamic nature of regulations and medical practices, staying informed and seeking professional advice can help to ensure a comprehensive and up-to-date approach to incorporating ketamine into mental health treatment.